Cargando…

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments

BACKGROUND: There is increasing evidence of the effectiveness of immune checkpoint blockade (ICB) therapy for the treatment of lung adenocarcinoma (LUAD). However, the benefits of ICB therapy vary among LUAD patients. Due to the research dimension, existing biomarkers, such as programmed death-ligan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chenghao, Lu, Tong, Xu, Ran, Chang, Xiaoyan, Luo, Shan, Peng, Bo, Wang, Jun, Yao, Lingqi, Wang, Kaiyu, Shen, Zhiping, Zhao, Jiaying, Zhang, Linyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264088/ https://www.ncbi.nlm.nih.gov/pubmed/35813746 http://dx.doi.org/10.21037/jtd-22-494

Ejemplares similares

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma
por: Chang, Xiaoyan, et al.
Publicado: (2022)

Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy
por: Wang, Chenghao, et al.
Publicado: (2022)

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Single-cell data analysis of malignant epithelial cell heterogeneity in lung adenocarcinoma for patient classification and prognosis prediction
por: Ran, Xu, et al.
Publicado: (2023)

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer
por: Peng, Bo, et al.
Publicado: (2023)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis
por: Li, Huawei, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
por: Zhou, Lingqi, et al.
Publicado: (2018)

Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development
por: Zhao, Jiaying, et al.
Publicado: (2022)

Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis
por: Yao, Yixing, et al.
Publicado: (2023)

A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
por: Ma, Jiayu, et al.
Publicado: (2021)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis
por: Chen, Binyu, et al.
Publicado: (2023)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses
por: Li, Tian-Hao, et al.
Publicado: (2023)

Identification of prognostic risk factors for esophageal adenocarcinoma using bioinformatics analysis
por: Dong, Zhiyu, et al.
Publicado: (2018)

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
por: Zheng, Qunhao, et al.
Publicado: (2021)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
por: Zhang, Peng, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma
por: Hou, Shaohui, et al.
Publicado: (2022)

Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis
por: Hou, Jili, et al.
Publicado: (2021)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis
por: Qiang, Weijie, et al.
Publicado: (2020)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma
por: Wang, Jiayi, et al.
Publicado: (2023)

Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study
por: Wu, Guolin, et al.
Publicado: (2020)

Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma
por: Pi, Yilin, et al.
Publicado: (2022)

Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches
por: Jiang, Jing, et al.
Publicado: (2023)

USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration
por: Wang, Yizhi, et al.
Publicado: (2022)

The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery
por: Wang, Jun, et al.
Publicado: (2022)

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma
por: Zuo, Ran, et al.
Publicado: (2023)

Construction of cuproptosis‑associated prognostic signature in colon adenocarcinoma based on bioinformatics and RT‑qPCR analysis
por: Yang, Guang, et al.
Publicado: (2023)

Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis
por: Yi, Yunhua, et al.
Publicado: (2022)

An immune-related gene prognostic risk index for pancreatic adenocarcinoma
por: Su, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p61ltg0d7cl29ahujp3kkg3evm